Epigral Share Price Today | Stock Price & Epigral Share Screener

Track the current stock price of Epigral with an interactive chart. Analyse EPIGRAL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Epigral stock quote in one place.

The quote of ₹1,017.30 sits between the 52-week low of ₹810.45 and the 52-week high of ₹1,706.50, and the latest session moved 3.57% from the previous close.

Screen Epigral company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for EPIGRAL shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Chemicals sector and the Specialty Chemicals industry, and it trades under ISIN INE071N01016.

Classification

Identifiers and Leadership

Screen EPIGRAL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹3,152, up from ₹2,794 in 2024.

Latest statistics put total assets at ₹3,152 and shareholder funds at ₹1,905, with a leverage ratio of 0.67.

Screen Epigral income statement and profit fundamentals. Analyze EPIGRAL quarterly results. Epigral reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2025-Dec, revenue was ₹603 and net profit was ₹39, equal to earnings per unit of ₹9.07, at an operating margin of 17%.

In that period expenses were ₹494, interest cost ₹11 and tax ₹16. The next period listed, 2025-Sept, shows revenue of ₹589 and net profit of ₹51.

Screen EPIGRAL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2024-March, operating activities generated ₹398, and net cash flow was an outflow of ₹11.

Over the same period, investing activities used ₹401 and financing activities used ₹8.

See Epigral shareholding pattern with promoter, FII, and DII holdings. Check Epigral promoter holding and ownership changes for EPIGRAL on TickJournal, and see how institutional stock price moves affect the market.

In 2025-Mar, promoters held 68.95%, foreign institutions 3.01%, domestic institutions 4.66% and the public 16.98%, spread across 80,878 shareholders.

The shareholder count was 80,878 in 2025-Mar, compared with 79,951 in 2025-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Epigral. Epigral dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹6.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹6.00 and ₹5.00 per unit.

See which indices include Epigral stock. Check EPIGRAL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 5 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX CARBON, BSE INDEX SMLCAP, NIFTY MICROCAP250.

Get Epigral corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Epigral stock events that may affect EPIGRAL share price, along with derivatives, futures and options activity and sector gainers.

14 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated January 30, 2026, with a record date of January 30, 2026.

It is followed by Quarterly Result Announcement dated November 10, 2025 and Quarterly Result Announcement dated August 2, 2025.

Screen EPIGRAL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen EPIGRAL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 26, 2026.

The next most recent announcements are dated March 6, 2026 and February 27, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 5 balance sheet periods, 15 income statement periods, 4 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.